Amyloid fibril formation kinetics of low-pH denatured bovine PI3K-SH3 monitored by three different NMR techniques

Amyloid fibril formation kinetics of low-pH denatured bovine PI3K-SH3 monitored by three different NMR techniques

Introduction: Misfolding of amyloidogenic proteins is a molecular hallmark of neurodegenerative diseases in humans. A detailed understanding of the underlying molecular mechanisms is mandatory for developing innovative therapeutic approaches. The bovine PI3K-SH3 domain has been a model system for ag...

Full description

Bibliographic Details
Main Authors:	Luis Gardon, Nina Becker, Nick Rähse, Christoph Hölbling, Athina Apostolidis, Celina M. Schulz, Kevin Bochinsky, Lothar Gremer, Henrike Heise, Nils-Alexander Lakomek
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-11-01
Series:	Frontiers in Molecular Biosciences
Subjects:	amyloid fibrils fibrillation aggregation kinetics NMR spectroscopy PI3K-SH3 neurodegeneration
Online Access:	https://www.frontiersin.org/articles/10.3389/fmolb.2023.1254721/full

Similar Items

Structural Characterization of Fibrils from Recombinant Human Islet Amyloid Polypeptide by Solid-State NMR: The Central FGAILS Segment Is Part of the β-Sheet Core.
by: Franziska Weirich, et al.
Published: (2016-01-01)

Omega-3 Index and Anti-Arrhythmic Potential of Omega-3 PUFAs
by: Narcis Tribulova, et al.
Published: (2017-10-01)

Galectin-3 in patients with atrial fibrillation and restored sinus rhythm
by: Antoniya Kisheva, et al.
Published: (2021-06-01)

Formation of amyloid fibrils by the regulatory 14-3-3ζ protein
by: Darius Šulskis, et al.
Published: (2024-01-01)

Plasma Galectin-3 is associated with progression from paroxysmal to persistent atrial fibrillation
by: Qianhui Wang, et al.
Published: (2021-05-01)

Atomic structure of PI3-kinase SH3 amyloid fibrils by cryo-electron microscopy
by: Christine Röder, et al.
Published: (2019-08-01)

A common food additive (E452), hexametaphosphate, denatures the digestive enzyme trypsin
by: Ajamaluddin Malik, et al.
Published: (2023-12-01)

The Role of Galectin-3 in Heart Failure—The Diagnostic, Prognostic and Therapeutic Potential—Where Do We Stand?
by: Beata Zaborska, et al.
Published: (2023-08-01)

Serum galectin-3 level predicts early recurrence following successful direct-current cardioversion in persistent atrial fibrillation patients
by: Kadri Murat Gürses, et al.
Published: (2019-10-01)

Colchicine in atrial fibrillation: are old trees in bloom?
by: Yujia Zhan, et al.
Published: (2023-10-01)

Honokiol Inhibits Atrial Metabolic Remodeling in Atrial Fibrillation Through Sirt3 Pathway
by: Guang Zhong Liu, et al.
Published: (2022-03-01)

3D Atrial Strain for Predicting Recurrence of Atrial Fibrillation after Pulmonary Vein Isolation
by: Iva Krizanovic-Grgic, et al.
Published: (2023-05-01)

The effects of omega-3 polyunsaturated fatty acids on cardiac rhythm: antiarrhythmic, proarrhythmic, both or neither?
by: Clemens evon Schacky
Published: (2012-04-01)

Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study
by: Sarah Berlin, et al.
Published: (2020-08-01)

3D printing for ablation planning in patients undergoing atrial fibrillation ablation: Preliminary results of the pilot randomized 3D GALA trial
by: Dimitrios Terentes-Printzios, et al.
Published: (2023-05-01)

GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01)

THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS
by: A. O. Malygin, et al.
Published: (2015-09-01)

Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes
by: Yoshio Takemoto, MD, PhD, et al.
Published: (2016-04-01)

The relationship between atrial fibrillation and NLRP3 inflammasome: a gut microbiota perspective
by: Yaxuan Xing, et al.
Published: (2023-11-01)

Fish, marine n-3 fatty acids, and atrial fibrillation - Experimental data and clinical effects
by: Thomas Andersen Rix, et al.
Published: (2012-05-01)

Galectin-3, N-terminal Propeptides of Type I and III Procollagen in Patients with Atrial Fibrillation and Metabolic Syndrome
by: Valery A. Ionin, et al.
Published: (2020-08-01)

Atrial fibrillation of new onset during acute illness: prevalence of, and risk factors for, persistence after hospital discharge
by: Abarna Ramanathan, et al.
Published: (2021-11-01)

Fibril core regions in engineered α-synuclein dimer are crucial for blocking of fibril elongation
by: Celina M. Schulz, et al.
Published: (2023-01-01)

Patient‐Reported Outcomes in Relation to Continuously Monitored Rhythm Before and During 2 Years After Atrial Fibrillation Ablation Using a Disease‐Specific and a Generic Instrument
by: Anna Björkenheim, et al.
Published: (2018-03-01)

Analysis of the Correlation of Galectin-3 Concentration with the Measurements of Echocardiographic Parameters Assessing Left Atrial Remodeling and Function in Patients with Persistent Atrial Fibrillation
by: Paweł Wałek, et al.
Published: (2021-07-01)

Omega-3 polyunsaturated fatty acids in the prevention of postoperative atrial fibrillation in open heart surgery: a systematic review and meta-analysis
by: O. A. Rubanenko, et al.
Published: (2023-03-01)

Trastuzumab increases pulmonary vein arrhythmogenesis through modulating pulmonary vein electrical and conduction properties via phosphatidylinositol 3-kinase signaling
by: Jun-Hei Chang, et al.
Published: (2020-07-01)

Disordered GPR43/NLRP3 expression in peripheral leukocytes of patients with atrial fibrillation is associated with intestinal short chain fatty acids levels
by: Chen Fang, et al.
Published: (2024-04-01)

Effects of n-3 polyunsaturated fatty acids on cardiac ion channels
by: Cristina eMoreno, et al.
Published: (2012-07-01)

IRX3 variant as a modifier of Brugada syndrome with frequent ventricular fibrillation
by: Yoshitaka Kimura, MD, et al.
Published: (2016-11-01)

Laboratory biomarker galectin-3 in the diagnostics of myocardial inflammatory changes in patients with atrial fibrillation
by: A. M. Gusakova, et al.
Published: (2023-06-01)

Cardiac fibrillation-defibrillation : clinical and engineering aspects /
by: Valentinuzzi, Max E., 1932-
Published: (2010)

Atrial Fibrillation in Wolff-Parkinson-White Syndrome
by: Andy Kieu, DO, et al.
Published: (2019-10-01)

The Amyloid Fibril-Forming β-Sheet Regions of Amyloid β and α-Synuclein Preferentially Interact with the Molecular Chaperone 14-3-3ζ
by: Danielle M. Williams, et al.
Published: (2021-10-01)

Omega-3 fatty acids and atrial fibrillation
by: Ji Hye Huh, et al.
Published: (2023-05-01)

Modulation Effects of Fe<sup>3+</sup>, Zn<sup>2+</sup>, and Cu<sup>2+</sup> Ions on the Amyloid Fibrillation of α-Synuclein: Insights from a FTIR Investigation
by: Yan Li, et al.
Published: (2022-12-01)

Correlation between serum homocysteine, Galectin-3 concentration and atrial structural remodeling in atrial fibrillation patients
by: Sun Xuhui, et al.
Published: (2020-05-01)

The Diagnostic and Therapeutic Potential of Galectin-3 in Cardiovascular Diseases
by: Grażyna Sygitowicz, et al.
Published: (2021-12-01)

Association Between Omega‐3 Fatty Acid Levels and Risk for Incident Major Bleeding Events and Atrial Fibrillation: MESA
by: Karan Kapoor, et al.
Published: (2021-06-01)

Two Novel Functional Mutations in Promoter Region of <i>SCN3B</i> Gene Associated with Atrial Fibrillation
by: Liyan Lin, et al.
Published: (2022-11-01)